Class III — Low Risk

Low risk — use of or exposure to this product is not likely to cause adverse health consequences.

is a quantitative/qualitative enzyme-linked immunosorbent assay (ELISA) for the detection Recalled by Euro Diagnostica AB Due to Incorrectly labeled Manufactured by DiaSorin, The correct term...

Date: October 21, 2016
Company: Euro Diagnostica AB
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Euro Diagnostica AB directly.

Affected Products

is a quantitative/qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of IgG and IgM autoantibodies specific for the phospholipid cardiolipin in human serum and EDTA, lithium heparin or citrated plasma. It is intended to assess of anti-cardiolipin IgG autoantibody levels in patients where this information is useful in diagnosis, particularly in the assessment of thrombotic risk in patients with systemic lupus erythematosus, or other lupus-like disorders

Quantity: 6

Why Was This Recalled?

Incorrectly labeled Manufactured by DiaSorin, The correct term should be Distributed by DiaSorin.

Where Was This Sold?

This product was distributed to 1 state: MN

Affected (1 state)Not affected

About Euro Diagnostica AB

Euro Diagnostica AB has 8 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report